Michigan Medicare-Medicaid Quality Withhold Updates for DY 2-10
Relevant to: PDP, State Medicare-Medicaid Plan Handbooks
Each week, we scan the latest CMS memos to find the most important ones that apply for PACE programs. Below is a summary of what you need to know.
Disclaimer: The content provided on this site is a summary for informational purposes only, and Grane PBM, Inc. assumes no liability for any errors or omissions in the site’s content. The information does not constitute legal or regulatory advice or replace the original CMS memo. Readers are advised to consult the CMS memo in its entirety and to verify information independently before making any decisions based on this information.
Click here to read the complete memo from CMS.
Introduction
The Medicare-Medicaid Coordination Office has unveiled the Michigan Quality Withhold Measure Technical Notes for Demonstration Years 2 through 10. These notes provide Michigan Medicare-Medicaid Plans with essential details on state-specific quality withhold measures, crucial for the ongoing Financial Alignment Initiative. Notifying changes, the document also marks the retirement of the Antidepressant Medication Management measure for effective acute phase treatment. For inquiries, stakeholders are encouraged to reach out via the provided contact email.
Key Dates and Deadlines
- Memo Date: November 5, 2024
- Retirement of Measure MIW10: Effective Measurement Year 2025
PACE Compliance
This memo is relevant to PACE programs because it outlines specific quality withhold measures and requirements for the Medicare-Medicaid Financial Alignment Initiative, which may impact similar demonstration projects under PACE.
Under this demonstration, Michigan Medicare-Medicaid Plans (MMPs) have state-specific quality measures they are accountable for, which supplement CMS Core Quality Withhold Measures. PACE plans need to ensure any similar state-specific quality measures are met to maintain compliance.
The retirement of measures, like the MIW10 – Antidepressant Medication Management – Effective Acute Phase Treatment for DY 10, signifies that PACE plans must stay informed and responsive to changes in quality metrics and adjust their compliance strategies accordingly. This ensures that plans remain aligned with both state-specific and national quality standards.
PACE organizations should also review and understand any revised technical notes related to quality withhold measures to thoroughly comprehend their responsibilities.
Required Actions
The purpose of this memorandum is to announce the release of updated Demonstration Years (DY) 2 through 10 state-specific quality withhold technical notes for MI Health Link, the Michigan capitated model demonstration under the Medicare-Medicaid Financial Alignment Initiative. The document provides additional details and benchmarks for the state-specific quality withhold measures that Michigan Medicare-Medicaid Plans (MMPs) are responsible for under the demonstration. These state-specific measures directly supplement the Medicare-Medicaid Capitated Financial Alignment Model CMS Core Quality Withhold Technical Notes for DY 2 through 12.
CMS and the state revised the Michigan Quality Withhold Measure Technical Notes to retire measure MIW10 – Antidepressant Medication Management – Effective Acute Phase Treatment for DY 10. We are retiring this measure because the measure steward (NCQA) has retired the measure for measurement year 2025.
FAQs
- “What are the Michigan Quality Withhold Measure Technical Notes?”
- “Which demonstration years do the updated technical notes cover?”
- “Why was the Antidepressant Medication Management measure retired for DY 10?”
- “Where can I find more information about the Michigan capitated model demonstration?”
- “What should I do if I have questions about the memorandum?”
